About Desentum
Desentum is a biotechnology company in Finland developing an allergy vaccine that harnesses the immune system.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
Espoo, Finland
Tracked Since
Oct 15, 2026
Web & Domain Identity
Official Website
desentum.fi
Domain Registered Date
Jan 23, 2013
Social & Network Presence
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $31,310,000 · Round
Backed by Springvest
- Milestone
X account created (@desentumAIT)
56 followers
- Milestone
Website domain registered
desentum.fi
Investors & Backers
Cascara Ventures
European Innovation Council Fund
Luxembourgian ACME Investments
Springvest
Sto-Rahoitus
VTT Ventures
Funding History
Round equity
· Oct 12, 2026
Round backers: Springvest
$31,310,000 european-biotechnology.com
Founders & Leadership
Pekka Mattila
Founder
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026